Liangxian Cao Selected Research

PTC-028

10/2018	Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.
1/2018	Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liangxian Cao Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 10/2011
2	Leukemia 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 08/2020
2	COVID-19 01/2021 - 08/2020
2	Adenocarcinoma 01/2019 - 01/2016
2	Hypoxia (Hypoxemia) 07/2016 - 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 10/2021
1	Leiomyosarcoma 10/2021
1	Diffuse Intrinsic Pontine Glioma 10/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 10/2018
1	Carcinosarcoma 10/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Ovarian Epithelial Carcinoma 01/2018
1	Tics (Tic) 12/2016
1	Prostatic Neoplasms (Prostate Cancer) 12/2016
1	Virus Diseases (Viral Diseases) 07/2016
1	Lymphoma (Lymphomas) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016

Drug/Important Bio-Agent (IBA)

5	emvododstatIBA 01/2022 - 07/2016
5	Pharmaceutical PreparationsIBA 10/2021 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 10/2018 - 10/2011
3	CytokinesIBA 01/2021 - 01/2016
2	Dihydroorotate DehydrogenaseIBA 01/2022 - 01/2019
2	NucleotidesIBA 01/2022 - 01/2019
2	pyrimidineIBA 01/2022 - 01/2019
2	PTC596IBA 10/2021 - 06/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2016
2	PTC-028IBA 10/2018 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2018 - 01/2018
2	Stem Cell FactorIBA 10/2018 - 01/2018
1	TubulinIBA 10/2021
1	Temozolomide (Temodar)FDA LinkGeneric 10/2021
1	Dacarbazine (DIC)FDA LinkGeneric 10/2021
1	Phosphotransferases (Kinase)IBA 01/2019
1	Uracil NucleotidesIBA 01/2019
1	Biological ProductsIBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	EnzymesIBA 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 10/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 06/2018
1	ibrutinibIBA 06/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 12/2016
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Cytotoxins (Cytolysins)IBA 10/2011
1	Small Interfering RNA (siRNA)IBA 10/2011

Therapy/Procedure

9	Therapeutics 01/2021 - 10/2011
1	Transplantation 01/2019
1	Oral Administration 01/2016